Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jacks

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Genes & Development|July 1, 1996
Shared role of the pRB-related p130 and p107 proteins in limb developmentD Cobrinik, M H Lee, G Hannon, et al.
Genes & Development|October 23, 1997
K-ras is an essential gene in the mouse with partial functional overlap with N-rasL Johnson, D Greenbaum, K Cichowski, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Apoptosis and the prognostic significance of p53 mutationS W Lowe, S Bodis, N Bardeesy, et al.
Endocrinology|March 31, 1999
Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediationK D Schleim, T Jacks, P Cunningham, et al.
Cell|November 23, 1992
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaM B Kastan, Q Zhan, W S el-Deiry, et al.
Science (New York, N.Y.)|June 11, 1993
A nonpeptidyl growth hormone secretagogueR G Smith, K Cheng, W R Schoen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoproteinR J Slebos, M H Lee, B S Plunkett, et al.
Cancer Research|November 21, 2000
Sex hormone-induced carcinogenesis in Rb-deficient prostate tissueY Wang, S W Hayward, A A Donjacour, et al.
Nature Genetics|February 1, 1996
Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cellsG Bollag, D W Clapp, S Shih, et al.
Journal of Medicinal Chemistry|July 3, 1998
1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]- 3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogueL Yang, G Morriello, A A Patchett, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Genes & Development|July 1, 1996
Shared role of the pRB-related p130 and p107 proteins in limb developmentD Cobrinik, M H Lee, G Hannon, et al.
Genes & Development|October 23, 1997
K-ras is an essential gene in the mouse with partial functional overlap with N-rasL Johnson, D Greenbaum, K Cichowski, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Apoptosis and the prognostic significance of p53 mutationS W Lowe, S Bodis, N Bardeesy, et al.
Endocrinology|March 31, 1999
Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediationK D Schleim, T Jacks, P Cunningham, et al.
Cell|November 23, 1992
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaM B Kastan, Q Zhan, W S el-Deiry, et al.
Science (New York, N.Y.)|June 11, 1993
A nonpeptidyl growth hormone secretagogueR G Smith, K Cheng, W R Schoen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoproteinR J Slebos, M H Lee, B S Plunkett, et al.
Cancer Research|November 21, 2000
Sex hormone-induced carcinogenesis in Rb-deficient prostate tissueY Wang, S W Hayward, A A Donjacour, et al.
Nature Genetics|February 1, 1996
Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cellsG Bollag, D W Clapp, S Shih, et al.
Journal of Medicinal Chemistry|July 3, 1998
1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]- 3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogueL Yang, G Morriello, A A Patchett, et al.
Pageof 13